- Home
- KMDA vs FRPH Comparison
KMDA vs FRPH Comparison
Compare KMDA & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- FRPH
- Stock Information
- Founded
- KMDA 1990
- FRPH 1986
- Country
- KMDA Israel
- FRPH United States
- Employees
- KMDA N/A
- FRPH N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- KMDA Health Care
- FRPH Finance
- Exchange
- KMDA Nasdaq
- FRPH Nasdaq
- Market Cap
- KMDA 410.6M
- FRPH 482.5M
- IPO Year
- KMDA N/A
- FRPH N/A
- Fundamental
- Price
- KMDA $6.95
- FRPH $25.00
- Analyst Decision
- KMDA Strong Buy
- FRPH
- Analyst Count
- KMDA 2
- FRPH 0
- Target Price
- KMDA $13.00
- FRPH N/A
- AVG Volume (30 Days)
- KMDA 50.0K
- FRPH 37.2K
- Earning Date
- KMDA 11-12-2025
- FRPH 11-05-2025
- Dividend Yield
- KMDA 2.90%
- FRPH N/A
- EPS Growth
- KMDA 27.97
- FRPH N/A
- EPS
- KMDA 0.32
- FRPH 0.28
- Revenue
- KMDA $169,517,000.00
- FRPH $32,293,999.00
- Revenue This Year
- KMDA $14.49
- FRPH N/A
- Revenue Next Year
- KMDA $10.12
- FRPH N/A
- P/E Ratio
- KMDA $20.92
- FRPH $89.33
- Revenue Growth
- KMDA 9.67
- FRPH 3.18
- 52 Week Low
- KMDA $5.17
- FRPH $24.72
- 52 Week High
- KMDA $9.16
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- KMDA 44.35
- FRPH 44.03
- Support Level
- KMDA $6.84
- FRPH $24.75
- Resistance Level
- KMDA $7.15
- FRPH $25.49
- Average True Range (ATR)
- KMDA 0.19
- FRPH 0.43
- MACD
- KMDA -0.00
- FRPH -0.01
- Stochastic Oscillator
- KMDA 23.02
- FRPH 28.97
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).